相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The drug-target residence time model: a 10-year retrospective
Robert A. Copeland
NATURE REVIEWS DRUG DISCOVERY (2016)
A review of caffeine's effects on cognitive, physical and occupational performance
Tom M. McLellan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain
Mehran Nikan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors
Ramon Guixa-Gonzalez et al.
SCIENTIFIC REPORTS (2016)
Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents
Giulio Casi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery
Jennica L. Zaro
AAPS JOURNAL (2015)
Uncovering Caffeine's Adenosine A(2A) Receptor Inverse Agonism in Experimental Parkinsonism
Victor Fernandez-Duenas et al.
ACS CHEMICAL BIOLOGY (2014)
Polyunsaturated fatty acids and their metabolites in brain function and disease
Richard P. Bazinet et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Anu Puri et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R
Victor Fernandez-Duenas et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Impact of omega-3 fatty acids in Parkinson's disease
Melanie Bousquet et al.
AGEING RESEARCH REVIEWS (2011)
Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
A. F. Ramlackhansingh et al.
NEUROLOGY (2011)
A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease
Katia Varani et al.
FASEB JOURNAL (2010)
Effects of Caffeine in Parkinson's Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms
Rui D. S. Prediger
JOURNAL OF ALZHEIMERS DISEASE (2010)
Caffeine and CSC, adenosine A(2A) antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells
Helio Vitoriano Nobre et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Prospective study of coffee consumption and risk of Parkinson's disease
K. Saaksjarvi et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2008)
Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: Evidence from animal studies
Frederic Calon et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: Opportunities for intervention
Joseph R. Hibbeln et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2006)
Analysis of apoptosis by propidium iodide staining and flow cytometry
Carlo Riccardi et al.
NATURE PROTOCOLS (2006)
Neuroprotective agents for clinical trials in Parkinson's disease - A systematic assessment
BM Ravina et al.
NEUROLOGY (2003)
Mechanisms of action of docosahexaenoic acid in the nervous system
N Salem et al.
LIPIDS (2001)
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
A Ascherio et al.
ANNALS OF NEUROLOGY (2001)
Association of coffee and caffeine intake with the risk of Parkinson disease
GW Ross et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
